Stay updated on Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A unified Locations section listing study sites by state (California, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New York, North Carolina, Ohio, Texas) was added, and the previous state-specific location subsections were removed. The revision tag updated from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:23:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page, indicating a minor version update with no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:07.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Publications section updates add clarifications that publications are provided voluntarily by the study submitter and that PubMed data is auto-filled and may not always pertain to the study; a system revision tag v3.3.1 was added. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-24T14:44:45.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:54:47.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The new screenshot shows only cosmetic layout and styling updates to the study page; the study content, eligibility criteria, and locations remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:20:59.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T10:14:44.000Z thumbnail image

Stay in the know with updates to Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.